Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. 2022

Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
IRIM, CNRS, Montpellier University, Montpellier, France.

CRISPR knockout (KO) screens have identified host factors regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication. Here, we conducted a meta-analysis of these screens, which showed a high level of cell-type specificity of the identified hits, highlighting the necessity of additional models to uncover the full landscape of host factors. Thus, we performed genome-wide KO and activation screens in Calu-3 lung cells and KO screens in Caco-2 colorectal cells, followed by secondary screens in four human cell lines. This revealed host-dependency factors, including AP1G1 adaptin and ATP8B1 flippase, as well as inhibitors, including mucins. Interestingly, some of the identified genes also modulate Middle East respiratory syndrome coronavirus (MERS-CoV) and seasonal human coronavirus (HCoV) (HCoV-NL63 and HCoV-229E) replication. Moreover, most genes had an impact on viral entry, with AP1G1 likely regulating TMPRSS2 activity at the plasma membrane. These results demonstrate the value of multiple cell models and perturbational modalities for understanding SARS-CoV-2 replication and provide a list of potential targets for therapeutic interventions.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D012621 Seasons Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Seasonal Variation,Season,Seasonal Variations,Variation, Seasonal,Variations, Seasonal
D018938 Caco-2 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation. Caco 2 Cells,Caco-2 Cell,Cell, Caco-2,Cells, Caco-2
D064112 Clustered Regularly Interspaced Short Palindromic Repeats Repetitive nucleic acid sequences that are principal components of the archaeal and bacterial CRISPR-CAS SYSTEMS, which function as adaptive antiviral defense systems. CRISPR Arrays,CRISPR Clusters,CRISPR Elements,CRISPR Loci,CRISPR Locus,CRISPR Sequences,CRISPR Spacer Sequences,CRISPR Spacers,CRISPR-Cas Loci,CRISPRs,Clustered Regularly Interspaced Short Palindromic Repeat,Array, CRISPR,Arrays, CRISPR,CRISPR,CRISPR Array,CRISPR Cas Loci,CRISPR Cluster,CRISPR Element,CRISPR Sequence,CRISPR Spacer,CRISPR Spacer Sequence,CRISPR-Cas Locus,Cluster, CRISPR,Clusters, CRISPR,Element, CRISPR,Elements, CRISPR,Loci, CRISPR,Loci, CRISPR-Cas,Locus, CRISPR,Locus, CRISPR-Cas,Sequence, CRISPR,Sequence, CRISPR Spacer,Sequences, CRISPR,Sequences, CRISPR Spacer,Spacer Sequence, CRISPR,Spacer Sequences, CRISPR,Spacer, CRISPR,Spacers, CRISPR
D065207 Middle East Respiratory Syndrome Coronavirus A coronavirus first reported in the summer of 2012 in a pneumonia patient in SAUDI ARABIA. It is related to SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. MERS-CoV has an estimated incubation period of 12 days and symptoms include renal failure and severe acute pneumonia with often fatal outcome. Merbecovirus,MERS Virus,MERS-CoV,Middle East respiratory syndrome-related coronavirus,MERS Viruses,Merbecoviruses,Middle East respiratory syndrome related coronavirus,Virus, MERS

Related Publications

Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
January 2021, Cell,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
August 2022, Nature genetics,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
February 2021, Nature communications,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
April 2022, Nature communications,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
June 2020, bioRxiv : the preprint server for biology,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
April 2021, Nature genetics,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
September 2022, Viruses,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
September 2020, Genomics & informatics,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
November 2018, PLoS genetics,
Antoine Rebendenne, and Priyanka Roy, and Boris Bonaventure, and Ana Luiza Chaves Valadão, and Lowiese Desmarets, and Mary Arnaud-Arnould, and Yves Rouillé, and Marine Tauziet, and Donatella Giovannini, and Jawida Touhami, and Yenarae Lee, and Peter DeWeirdt, and Mudra Hegde, and Serge Urbach, and Khadija El Koulali, and Francisco Garcia de Gracia, and Joe McKellar, and Jean Dubuisson, and Mélanie Wencker, and Sandrine Belouzard, and Olivier Moncorgé, and John G Doench, and Caroline Goujon
June 2019, The Journal of biological chemistry,
Copied contents to your clipboard!